Jennison Associates
FSTX

Jennison Associates’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Jennison Associates’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-132,320
Closed -$5.55M – 682
2019
Q1 		$5.55M Sell
132,320
-22
-0% -$927 0.01% 466
2018
Q4 		$5.5M Sell
132,342
-37,991
-22% -$1.71M 0.01% 478
2018
Q3 		$8.21M Buy
+170,333
New +$8.53M 0.01% 485

Other funds holding FSTX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TA
Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jennison Associates's FSTX Position: Q2 2019 in Review

Jennison Associates sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q2 2019, closing a stake of 132,320 shares — an estimated $5.55M sold.

Jennison Associates first reported a position in FSTX in Q3 2018 and held it in 3 quarters. The position peaked at $8.21M in Q3 2018. 50 funds tracked by Wall St. Rank hold FSTX as of Q2 2019.

  • Jennison Associates reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Jennison Associates sold 132,320 F-star Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $5.55M.
  • Jennison Associates first reported a position in F-star Therapeutics, Inc. Common Stock in Q3 2018 and held it in 3 quarters.
  • Jennison Associates's F-star Therapeutics, Inc. Common Stock position peaked at $8.21M in Q3 2018.
  • 50 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Jennison Associates's 13F filing for Q2 2019, filed 6 Aug 2019.